Orthopediatrics (KIDS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access KIDS quarterly Cash Flow →
Looking at cash flow data from Orthopediatrics through Dec 31 2021 provides insight into Dec 31 2025's financial flexibility across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-39.65
Depreciation & amortization21.12
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-8.47
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation17.78
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Research And Development Fee Obligation Termination-
Increase Decreasein Research And Development Fee Obligation-
Temporary Equity Accretion To Redemption Value-
Business Combination Contingent Consideration Change In Fair Value Acquisition Installment Payable-
Impairment Of Intangible Assets Excluding Goodwill-
Transfer Of Property And Equipment To Inventory0.28
Increase Decrease In Settlement Liabilities Current-
Non Cash Other0.24
Business Combination Contingent Consideration Change In Fair Value Accretion Of Acquisition Installment Payable0.09
Income taxes-0.15
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Notes Receivable-9.37
Increase (Decrease) in Accounts Payable8.17
Increase (Decrease) in Accrued Liabilities1.25
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.41
Other Working Capital-2.79
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities6.23
Discontinued operations0.00
Net Cash flow from Operating Activities-4.85
Investing Activities
Capital Expenditures-11.11
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Marketable Securities-15.00
Real Estate Investments0.00
Stock Issued-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Stock Issued-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Stock Issued-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Stock Issued-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Stock Issued-
Payments To Acquire Business Four Net Of Cash Acquired-
Payments To Acquire Investments In Private Companies And Purchases Of Licenses Net-2.02
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Business Two, Net of Cash Acquired-15.50
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-43.63
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings25.00
Long-term debt - repayments-0.16
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.87
Installment Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities23.98
Effect of exchange rate on cash flow0.35
Discontinued operations0.00
Free Cash Flow-15.96
Total Cash Flow-24.16
4 historic quarters locked

Sign in to unlock the full Orthopediatrics cash flow history.

About Orthopediatrics Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001425450-26-000013

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License